Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hierarchical models for probabilistic dose-response assessment.

R L Kodell1, J J Chen, R R Delongchamp

  • 1Division of Biometry and Risk Assessment, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA. rkodell@nctr.fda.gov

Regulatory Toxicology and Pharmacology : RTP
|June 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cloning, expression and functional characterization of prepared bovine, salmon, and cod basic fibroblast growth factor-2.

NPJ science of food·2025
Same author

Psychological factors influencing consumer intentions to consume cultured meat, fish and dairy.

Appetite·2024
Same author

The Longitudinal Association between Self-esteem and Depressive Symptoms in Adolescents: Separating between-person effects from within-person effects.

European journal of personality·2019
Same author

Associations among gait score, production data, abattoir registrations, and postmortem tibia measurements in broiler chickens.

Poultry science·2016
Same author

In vitro digestion of purified β-casein variants A(1), A(2), B, and I: effects on antioxidant and angiotensin-converting enzyme inhibitory capacity.

Journal of dairy science·2014
Same author

Validation of biomarkers for loin meat quality (M. longissimus) of pigs.

Journal of animal breeding and genetics = Zeitschrift fur Tierzuchtung und Zuchtungsbiologie·2014
Same journal

Applying the Omics Data Analysis Framework for Regulatory Application (R-ODAF) filtering criteria: A Case Study with 3-Methylcholanthrene.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Cardiovascular toxicity as a globally harmonized system hazard trait: The evidence and the path forward.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

The NTP chronic inhalation study does not support an inherent lung cancer hazard of talc: Implications of lung particle overload and maximum tolerated dose.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Consideration of Carcinogenicity and Mode of Action Information by an Independent Expert Panel to Support Derivation of No-Significant-Risk-Level Values for Vinyl Acetate Monomer.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Which carcinogenicity study should I use? Automated identification of reliable studies.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Adoption of artificial intelligence in drug review across the lifecycle: Transformation of regulatory decision-making.

Regulatory toxicology and pharmacology : RTP·2026
See all related articles

Hierarchical statistical models enhance probabilistic risk assessments by linking pharmacokinetic and pharmacodynamic data. This approach reduces uncertainty in human health risk and benchmark dose estimations.

Area of Science:

  • Toxicology
  • Biostatistics
  • Pharmacokinetics and Pharmacodynamics

Background:

  • Probabilistic risk assessment (PRA) is increasingly adopted for characterizing human health risks and exposure levels.
  • While PRA is established in exposure assessment, its application in dose-response assessment is less developed.
  • Existing methods often struggle to integrate complex pharmacokinetic (PK) and pharmacodynamic (PD) relationships.

Purpose of the Study:

  • To propose hierarchical statistical models for probabilistic dose-response assessment.
  • To demonstrate how these models can integrate PK and PD information.
  • To evaluate the impact of internal dose variability on risk estimation uncertainty.

Main Methods:

  • Development and application of hierarchical statistical models.

Related Experiment Videos

  • Coupling of pharmacokinetic (PK) and pharmacodynamic (PD) models within a hierarchical framework.
  • Probabilistic analysis of dose-response relationships.

    • Main Results:

    • Hierarchical models effectively integrate PK and PD data, reducing uncertainty in risk assessments.
    • Information on the mean internal dose is sufficient; variance does not significantly impact uncertainty of excess risks or benchmark doses.
    • The complexity of the PK model does not alter the measurement of risk variability at the endpoint.

    Conclusions:

    • Hierarchical statistical models offer a robust framework for probabilistic dose-response assessment.
    • Integrating internal dose metrics via PK-PD coupling improves risk characterization.
    • Focusing on the mean internal dose is key for uncertainty reduction in PRA.